| (+)-N-Allylnormetazocine hydrochloride |
|
|
|
|
99.6% |
| (+)-Norpropoxyphene maleate |
|
|
|
|
|
| (+)-U-50488 |
|
|
|
|
|
| (+)-U-50488 hydrochloride |
|
|
|
|
|
| (-)-9-Hydroxycorynantheidine |
|
|
|
|
|
| (-)-P7C3-S243 |
|
|
|
|
|
| (-)-U-50488 hydrochloride |
|
|
|
|
98.95% |
| (1R,2R)-U-50488 hydrochloride |
|
|
|
|
99.14% |
| (D-Arg2, Sar 4)-Dermorphin (1-4) |
|
|
|
|
|
| (D-Met2,Pro5)-Enkephalinamide |
|
|
|
|
|
| (N-Me-Tyr1,N-Me-Arg7,D-Leu-NHEt8)-Dynorphin A (1-8) |
|
|
|
|
|
| (R)-(+)-Citronellal |
|
|
|
|
98.72% |
| (Rac)-Enadoline |
|
|
|
|
|
| (Rac)-SNC80 |
|
|
|
|
|
| (rel)-RSD 921 |
|
|
|
|
|
| (S)-MCOPPB |
|
|
|
|
98.97% |
| (S)-Laudanosine |
|
|
|
|
99.95% |
| (S,S)-J-113397 |
|
|
|
|
99.87% |
| (±)-J-113397 |
|
|
|
|
99.82% |
| (±)-Salsolinol hydrochloride |
|
|
|
|
98% |
| (±)-U-50488 |
|
|
|
|
|
| (±)-U-50488 hydrate hydrochloride |
|
|
|
|
99.76% |
| (±)-U-50488 hydrochloride |
|
|
|
|
99.73% |
| 1-(5-Fluoropentyl)-1H-indazole-3-carboxylic acid |
|
|
|
|
|
| 1-Naphthyl U-47700 |
|
|
|
|
|
| 2,4-Difluoro U-48800 hydrochloride |
|
|
|
|
|
| 2,6-Dimethyl-L-tyrosine |
|
|
|
|
99.94% |
| 2-(Di-sec-butylamino)-1-(1-(2-fluorobenzyl)-1H-pyrrol-2-yl)ethan-1-ol |
|
|
|
|
|
| 2-Naphthyl U-47700 |
|
|
|
|
|
| 22-Thiocyanatosalvinorin A |
|
|
|
|
|
| 3,4-Difluoro isopropyl U-47700 |
|
|
|
|
|
| 3,4-Difluoro propyl U-47700 |
|
|
|
|
|
| 3,4-Difluoro U-49900 hydrochloride |
|
|
|
|
|
| 3,4-Difluoro U-50488 hydrochloride |
|
|
|
|
|
| 3,4-Difluoro-N,N-didesmethyl U-47700 TFA |
|
|
|
|
|
| 3,4-Difluoro-N-desmethyl U-47700 hydrochloride |
|
|
|
|
|
| 3,4-Ethylenedioxy U-51754 hydrochloride |
|
|
|
|
|
| 3,4-Methylenedioxy U-47700 hydrochloride |
|
|
|
|
|
| 3-Carboxamidonaltrexone |
|
|
|
|
|
| 4-Hydroxy-1-(2-phenylethyl)piperidine |
|
|
|
|
|
| Vanilpyruvic acid |
|
|
|
|
98.08% |
| 5′-Guanidinonaltrindole |
|
|
|
|
|
| 5'-Guanidinonaltrindole hydrochloride |
|
|
|
|
98.06% |
| 6'-GNTI dihydrochloride |
|
|
|
|
|
| 6-Fluoro-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indole |
|
|
|
|
|
| 6-Hydroxyflavanone |
|
|
|
|
99.87% |
| 6β-Naltrexol |
|
|
|
|
99.03% |
| 6β-Naltrexol-d3 |
|
|
|
|
|
| 7-PET |
|
|
|
|
|
| [(pF)Phe4]Nociceptin(1-13)NH2 |
|
|
|
|
|
| [(pF)Phe4]Nociceptin(1-13)NH2 TFA |
|
|
|
|
|
| [Arg14,Lys15]Nociceptin |
|
|
|
|
|
| [Arg14,Lys15]Nociceptin TFA |
|
|
|
|
|
| BW-180C |
|
|
|
|
99.92% |
| [D-Ala2]-Met-Enkephalin |
|
|
|
|
|
| [D-Ala2]-Met-Enkephalinamide |
|
|
|
|
|
| [D-Ala2]leucine-enkephalin |
|
|
|
|
98.92% |
| [DAla2, DArg6] Dynorphin A, (1-13) (porcine) |
|
|
|
|
|
| [DAla2] Dynorphin A (1-13), amide (porcine) |
|
|
|
|
|
| [DAla2] Dynorphin A (1-9) (porcine) |
|
|
|
|
|
| [Des-Tyr1]-gamma-Endorphin |
|
|
|
|
|
| [Dmt1]DALDA |
|
|
|
|
|
| [DPen2, Pen5] Enkephalin |
|
|
|
|
|
| [DPro10] Dynorphin A (1-11), porcine |
|
|
|
|
|
| [DPro10] Dynorphin A (1-11), porcine hydrochloride |
|
|
|
|
|
| [Leu5]-Enkephalin TFA |
|
|
|
|
|
| [Leu5]-Enkephalin, amide |
|
|
|
|
99.76% |
| [Leu5]-Enkephalin |
|
|
|
|
99.92% |
| [Met5]-Enkephalin, amide |
|
|
|
|
|
| [Met5]-Enkephalin, amide TFA |
|
|
|
|
99.58% |
| [Nphe1]Nociceptin(1-13)NH2 |
|
|
|
|
|
| [Nphe1]Nociceptin(1-13)NH2 TFA |
|
|
|
|
|
| [Phe1Ψ(CH2-NH)Gly2]Nociceptin(1-13)NH2 |
|
|
|
|
|
| Ac-RYYRIK-NH2 |
|
|
|
|
|
| Ac-RYYRIK-NH2 TFA |
|
|
|
|
|
| Ac-RYYRWK-NH2 |
|
|
|
|
|
| Ac-RYYRWK-NH2 TFA |
|
|
|
|
|
| Acetalin-1 |
|
|
|
|
|
| Acetalin-2 |
|
|
|
|
|
| Acetalin-3 |
|
|
|
|
|
| Acetyl tetrapeptide-15 |
|
|
|
|
99.64% |
| ADL-5747 |
|
|
|
|
99.82% |
| ADL-5747 hydrochloride |
|
|
|
|
|
| ADL-5859 hydrochloride |
|
|
|
|
98.96% |
| ADL5859 |
|
|
|
|
|
| Adrenorphin |
|
|
|
|
98.84% |
| AH 7563 |
|
|
|
|
|
| AH 7959 |
|
|
|
|
|
| AH 8507 |
|
|
|
|
|
| AH 8529 |
|
|
|
|
|
| AH 8532 |
|
|
|
|
|
| AH-8533 |
|
|
|
|
|
| Akuammidine |
|
|
|
|
|
| Alimadol |
|
|
|
|
|
| Allyphenyline oxalate |
|
|
|
|
|
| Alvimopan metabolite hydrochloride |
|
|
|
|
99.93% |
| Amdakefalin |
|
|
|
|
|
| Anilopam |
|
|
|
|
|
| Anrikefon |
|
|
|
|
|
| Anrikefon acetate |
|
|
|
|
99.68% |
| AP-238 |
|
|
|
|
|
| AR-M 1000390 |
|
|
|
|
|
| AR-M 1000390 hydrochloride |
|
|
|
|
98.20% |
| AT-035 |
|
|
|
|
|
| AT-076 |
|
|
|
|
|
| AT-121 |
|
|
|
|
98.01% |
| AT-121 hydrochloride |
|
|
|
|
|
| AT-127 |
|
|
|
|
|
| Aticaprant |
|
|
|
|
99.59% |
| Atoxifent |
|
|
|
|
|
| AWL 60 |
|
|
|
|
|
| Axelopran |
|
|
|
|
|
| Axelopran sulfate |
|
|
|
|
99.14% |
| AZ 12488024 |
|
|
|
|
|
| AZD-2327 |
|
|
|
|
|
| Azo-enkephalin |
|
|
|
|
|
| BAM-12P |
|
|
|
|
|
| BAM-22P |
|
|
|
|
|
| BAN ORL 24 |
|
|
|
|
99.68% |
| BAN ORL 24 free base |
|
|
|
|
|
| Bevenopran |
|
|
|
|
99.09% |
| Bilaid A |
|
|
|
|
|
| Bilaid A1e |
|
|
|
|
|
| Bilaid B |
|
|
|
|
|
| Bilaid C |
|
|
|
|
|
| Biocytin-β-endorphin, human |
|
|
|
|
|
| Biphalin acetate |
|
|
|
|
|
| Biphalin TFA |
|
|
|
|
|
| Bipiperidinyl 4-ANPP |
|
|
|
|
|
| BMS-986121 |
|
|
|
|
99.96% |
| BMS-986122 |
|
|
|
|
99.90% |
| BMS-986124 |
|
|
|
|
99.00% |
| BMS-986187 |
|
|
|
|
99.66% |
| BMS-986188 |
|
|
|
|
99.06% |
| BNTX |
|
|
|
|
|
| BNTX maleate |
|
|
|
|
98.2% |
| Boc-YPGFL(O-tBu) |
|
|
|
|
|
| BPR1M97 |
|
|
|
|
99.42% |
| BPRMU191 |
|
|
|
|
|
| BRL 52537 hydrochloride |
|
|
|
|
98.14% |
| BRL-52656 |
|
|
|
|
|
| Bromadol |
|
|
|
|
|
| Bromadoline |
|
|
|
|
|
| Bromadoline maleate |
|
|
|
|
|
| BU09059 |
|
|
|
|
|
| BU72 |
|
|
|
|
|
| BW373U86 |
|
|
|
|
|
| BW443C |
|
|
|
|
|
| CA1001 |
|
|
|
|
|
| CCG258747 |
|
|
|
|
98.96% |
| CCI-1008 |
|
|
|
|
|
| CHIR 4531 |
|
|
|
|
|
| Chlorphine |
|
|
|
|
|
| CJ-15161 |
|
|
|
|
|
| CJ-15208 |
|
|
|
|
|
| Corynantheidine |
|
|
|
|
|
| CP-866,087 |
|
|
|
|
|
| CP-866087 |
|
|
|
|
|
| CR 665 |
|
|
|
|
99.66% |
| CR 665 acetate |
|
|
|
|
|
| CSD-CH2(1,8)-NH2 |
|
|
|
|
|
| CTAP |
|
|
|
|
99.30% |
| CTAP TFA |
|
|
|
|
99.60% |
| CTOP |
|
|
|
|
|
| CTOP TFA |
|
|
|
|
98.78% |
| CYM51010 |
|
|
|
|
98.28% |
| Cyprodime |
|
|
|
|
|
| Cyprodime hydrochloride |
|
|
|
|
|
| CYT-1010 |
|
|
|
|
99.28% |
| CYT-1010 hydrochloride |
|
|
|
|
|
| D-Ala-Gly-Phe-Met-NH2 |
|
|
|
|
|
| D-Ala-Gly-Phe-Met-NH2 monoacetate |
|
|
|
|
|
| D3R/MOR antagonist 1 |
|
|
|
|
|
| D3R/MOR antagonist 2 |
|
|
|
|
|
| Daeatal |
|
|
|
|
|
| Dafphedyn |
|
|
|
|
|
| Dalargin |
|
|
|
|
98.12% |
| DALDA |
|
|
|
|
|
| DALDA acetate |
|
|
|
|
99.78% |
| DALDA TFA |
|
|
|
|
|
| DAMGO |
|
|
|
|
99.82% |
| DAMGO TFA |
|
|
|
|
99.52% |
| DBPR116 |
|
|
|
|
|
| DDD-028 |
|
|
|
|
|
| Deltakephalin |
|
|
|
|
|
| Deltorphin |
|
|
|
|
|
| Deltorphin 2 |
|
|
|
|
|
| Deltorphin 2 TFA |
|
|
|
|
98.95% |
| Deltorphin I |
|
|
|
|
96.69% |
| Deltorphin I TFA |
|
|
|
|
|
| Dermorphin Analog |
|
|
|
|
|
| Desmethylmoramide |
|
|
|
|
|
| DH-1-106 |
|
|
|
|
|
| Diallyl G |
|
|
|
|
|
| Difelikefalin |
|
|
|
|
99.98% |
| Difelikefalin acetate |
|
|
|
|
|
| Difelikefalin-d5 |
|
|
|
|
|
| Difelikefalin-d5 hydrochloride |
|
|
|
|
97.58% |
| DIPPA hydrochloride |
|
|
|
|
99.7% |
| Dipyanone hydrochloride |
|
|
|
|
|
| DOR agonist 2 |
|
|
|
|
|
| DOR agonist 3 |
|
|
|
|
|
| Doxpicomine |
|
|
|
|
|
| DP32 |
|
|
|
|
|
| DP50 |
|
|
|
|
|
| DPDPE |
|
|
|
|
99.21% |
| DPDPE TFA |
|
|
|
|
99.81% |
| DPI-287 |
|
|
|
|
|
| DPI-3290 |
|
|
|
|
|
| DS34942424 |
|
|
|
|
|
| DS39201083 |
|
|
|
|
|
| DSLET |
|
|
|
|
|
| DuP 747 |
|
|
|
|
|
| DuP 747 hydrochloride |
|
|
|
|
|
| Dynorphin (2-17), amide (porcine) |
|
|
|
|
|
| Dynorphin A (1-10) |
|
|
|
|
|
| Dynorphin A (1-10) TFA |
|
|
|
|
98.64% |
| Dynorphin A (1-13) amide |
|
|
|
|
|
| Dynorphin A (1-8) |
|
|
|
|
99.69% |
| Dynorphin B (1-9) |
|
|
|
|
|
| Dynorphin B 29 (pig) |
|
|
|
|
|
| Enadoline hydrochloride |
|
|
|
|
|
| Endomorphin 1 acetate |
|
|
|
|
99.92% |
| ERG-IN-6 |
|
|
|
|
|
| Eseroline |
|
|
|
|
|
| EST73502 |
|
|
|
|
|
| EST73502 monohydrochloride |
|
|
|
|
99.58% |
| Faxeladol |
|
|
|
|
|
| FEKAP |
|
|
|
|
|
| FK 33-824 |
|
|
|
|
|
| Fluorphine |
|
|
|
|
|
| Frakefamide |
|
|
|
|
|
| Frakefamide TFA |
|
|
|
|
99.18% |
| Gluten Exorphin B5 |
|
|
|
|
99.68% |
| Gluten Exorphin C |
|
|
|
|
99.86% |
| GR 89696 |
|
|
|
|
99.88% |
| GR 89696 free base |
|
|
|
|
|
| GR103545 fumarate |
|
|
|
|
|
| GRT2932Q |
|
|
|
|
|
| GSK1521498 |
|
|
|
|
|
| GSK1521498 free base |
|
|
|
|
99.79% |
| GSK1521498 free base hydrochloride |
|
|
|
|
|
| Helianorphin-19 |
|
|
|
|
|
| Hemorphin-7 |
|
|
|
|
|
| Herkinorin |
|
|
|
|
|
| HINT1-IN-1 |
|
|
|
|
|
| Hodgkinsine |
|
|
|
|
|
| Hodgkinsine B |
|
|
|
|
|
| Icalcaprant |
|
|
|
|
|
| ICI 154129 |
|
|
|
|
95.16% |
| ICI 174864 |
|
|
|
|
98.84% |
| ICI-199441 |
|
|
|
|
|
| ICI-199441 hydrochloride |
|
|
|
|
99.30% |
| ICI-204448 |
|
|
|
|
98.09% |
| ICI-204448 free acid |
|
|
|
|
|
| ID110460001 |
|
|
|
|
|
| ID110460002 |
|
|
|
|
|
| Ignavine |
|
|
|
|
|
| Iprindole |
|
|
|
|
99.55% |
| Iprindole hydrochloride |
|
|
|
|
|
| Isopaynantheine |
|
|
|
|
|
| ITI-333 |
|
|
|
|
|
| J-113397 |
|
|
|
|
99.00% |
| JDTic |
|
|
|
|
|
| JDTic dihydrochloride |
|
|
|
|
98.03% |
| JNJ-20788560 |
|
|
|
|
98.05% |
| JO-1870 hydrochloride |
|
|
|
|
|
| JTC-801 |
|
|
|
|
98.67% |
| JTC-801 free base |
|
|
|
|
|
| K-Opioid receptor agonist-1 |
|
|
|
|
|
| Kentsin |
|
|
|
|
|
| Ketazocine |
|
|
|
|
|
| KK-103 |
|
|
|
|
|
| KNT-127 |
|
|
|
|
99.11% |
| KOR agonist 1 |
|
|
|
|
|
| KOR agonist 2 |
|
|
|
|
|
| KOR agonist 4 |
|
|
|
|
|
| KOR agonist 5 |
|
|
|
|
|
| KOR agonist 6 |
|
|
|
|
|
| KOR agonist 7 |
|
|
|
|
|
| KOR agonist 8 |
|
|
|
|
|
| KOR agonist-9 |
|
|
|
|
|
| KOR/DOR agonist 1 |
|
|
|
|
|
| Leumorphin, human |
|
|
|
|
|
| Lexanopadol |
|
|
|
|
|
| Loperamide |
|
|
|
|
99.85% |
| Loperamide-d6 |
|
|
|
|
98.88% |
| Loxicodegol |
|
|
|
|
|
| LPK-26 hydrochloride |
|
|
|
|
|
| LY-281217 |
|
|
|
|
|
| LY-99335 |
|
|
|
|
|
| LY164929 |
|
|
|
|
|
| LY2048978 |
|
|
|
|
|
| LY2444296 |
|
|
|
|
99.26% |
| LY255582 |
|
|
|
|
98% |
| LY2795050 |
|
|
|
|
98.12% |
| LY2940094 |
|
|
|
|
99.17% |
| LY2940094 tartrate |
|
|
|
|
99.66% |
| M119 |
|
|
|
|
|
| MCOPPB |
|
|
|
|
|
| MCOPPB trihydrochloride |
|
|
|
|
99.98% |
| MDAN-21 |
|
|
|
|
|
| Mesyl Salvinorin B |
|
|
|
|
|
| Met-Enkephalin-Arg-Phe |
|
|
|
|
|
| Meta-fluoro 4-ANBP |
|
|
|
|
|
| Methocinnamox |
|
|
|
|
|
| Methyl-6-alpha-Naltrexol |
|
|
|
|
|
| Methylketobemidone |
|
|
|
|
|
| Mianserin-d3 |
|
|
|
|
|
| Mitragynine pseudoindoxyl |
|
|
|
|
99.9% |
| MK-1925 |
|
|
|
|
|
| MK-5757 |
|
|
|
|
|
| ML 190 |
|
|
|
|
99.60% |
| ML 190 (Standard) |
|
|
|
|
|
| ML138 |
|
|
|
|
|
| MOR agonist-1 |
|
|
|
|
|
| MOR agonist-2 |
|
|
|
|
|
| MOR agonist-4 |
|
|
|
|
|
| MOR agonist-5 |
|
|
|
|
|
| MOR antagonist 2 hydrochloride |
|
|
|
|
|
| MOR modulator-1 |
|
|
|
|
|
| Morphiceptin |
|
|
|
|
99.07% |
| MPAM-15 |
|
|
|
|
|
| MR2034 |
|
|
|
|
|
| MT-7716 free base |
|
|
|
|
|
| MT-7716 hydrochloride |
|
|
|
|
99.06% |
| MT-7716 hydrochloride (Standard) |
|
|
|
|
|
| Mu opioid receptor agonist 1 |
|
|
|
|
|
| Mu opioid receptor antagonist 1 |
|
|
|
|
|
| Mu opioid receptor antagonist 2 |
|
|
|
|
|
| Mu opioid receptor antagonist 3 |
|
|
|
|
|
| Mu opioid receptor antagonist 4 |
|
|
|
|
|
| Mu opioid receptor antagonist 5 |
|
|
|
|
|
| Mu opioid receptor antagonist 7 |
|
|
|
|
|
| Mu opioid receptor antagonist 8 |
|
|
|
|
|
| Mu opioid receptor antagonist 9 |
|
|
|
|
|
| N,N-Diallyl-Tyr-Aib-Aib-Phe-Leu |
|
|
|
|
|
| N,N-didesmethyl AH 7921 |
|
|
|
|
|
| N-(1-Benzyl-4-piperidyl)-N-benzylpropanamide hydrochloride |
|
|
|
|
|
| N-(1-Phenethyl-4-piperidyl)-N-phenethylpropanamide hydrochloride |
|
|
|
|
|
| N-Acetyl-α-Endorphin |
|
|
|
|
|
| N-Benzylnaltrindole hydrochloride |
|
|
|
|
|
| N-Desmethyl-loperamide |
|
|
|
|
98.36% |
| N-Phenethylnoroxymorphone |
|
|
|
|
|
| N-Propionitrile Chlorphine hydrochloride |
|
|
|
|
98.6% |
| N-terminally acetylated Endomorphin-1 |
|
|
|
|
99.20% |
| N-terminally acetylated Leu-enkephalin |
|
|
|
|
99.49% |
| N-Desmethylclozapine-d8 |
|
|
|
|
98.73% |
| Naldemedine |
|
|
|
|
|
| Naldemedine tosylate |
|
|
|
|
90.0% |
| Nalmefene |
|
|
|
|
99.94% |
| Nalmefene Sulfate-d3 |
|
|
|
|
|
| Naloxegol-d5 oxalate |
|
|
|
|
|
| Naloxonazine |
|
|
|
|
|
| Naloxonazine dihydrochloride |
|
|
|
|
98.1% |
| Naloxone benzoylhydrazone |
|
|
|
|
98.36% |
| Naloxone methiodide |
|
|
|
|
99.7% |
| Naltriben |
|
|
|
|
|
| Naltriben mesylate |
|
|
|
|
99.65% |
| Naltrindole 5′-isothiocyanate |
|
|
|
|
|
| NAQ |
|
|
|
|
|
| Navacaprant |
|
|
|
|
99.88% |
| Neuropeptide AF (human) |
|
|
|
|
|
| Niravoline |
|
|
|
|
|
| NNC 63-0532 |
|
|
|
|
99.81% |
| Nociceptin (1-13), amide |
|
|
|
|
|
| Nociceptin (1-13), amide TFA |
|
|
|
|
99.87% |
| Nociceptin(1-7) |
|
|
|
|
|
| Nociceptin(1-7) TFA |
|
|
|
|
|
| Nocistatin |
|
|
|
|
|
| NOP agonist-1 |
|
|
|
|
|
| NOP agonist-2 |
|
|
|
|
|
| NOP antagonist 1 |
|
|
|
|
|
| Nor-6α-Oxycodol |
|
|
|
|
|
| nor-Binaltorphimine |
|
|
|
|
98.70% |
| Norbinaltorphimine dihydrochloride |
|
|
|
|
98.91% |
| Noribogaine hydrochloride |
|
|
|
|
99.90% |
| Noscapine-13C,d3 |
|
|
|
|
|
| NP-5497-KA |
|
|
|
|
|
| NPFF1-R antagonist 1 |
|
|
|
|
99.38% |
| O,O-Diethyl dithiophosphate-13C4 ammonium |
|
|
|
|
|
| O-Desmethyl Tramadol-d6 |
|
|
|
|
|
| O-Desmethyltramadol |
|
|
|
|
|
| O-Desmethyltramadol hydrochloride |
|
|
|
|
99.79% |
| O-Desmethyltramadol-d6 hydrochloride |
|
|
|
|
|
| Ondelopran |
|
|
|
|
|
| Opioid receptor agonist 1 |
|
|
|
|
|
| Opioid receptor antagonist 1 |
|
|
|
|
|
| Opioid receptor antagonist 2 |
|
|
|
|
|
| Opioid receptor modulator 1 |
|
|
|
|
|
| ORL1 antagonist 1 |
|
|
|
|
|
| ORL1 antagonist 2 |
|
|
|
|
|
| Orphanin FQ(1-11) |
|
|
|
|
99.83% |
| Orphanin FQ(1-11) TFA |
|
|
|
|
|
| Orphine |
|
|
|
|
|
| Ortho-methyl 4-anilino-1-boc-piperidine |
|
|
|
|
|
| PAD-PF2 |
|
|
|
|
99.94% |
| Peptide E |
|
|
|
|
|
| Perillyl acetate |
|
|
|
|
|
| PF-04455242 |
|
|
|
|
|
| PF-4455242 hydrochloride |
|
|
|
|
99.01% |
| Phenethyl 4-ANPP |
|
|
|
|
|
| Picenadol |
|
|
|
|
|
| Picenadol hydrochloride |
|
|
|
|
|
| Picraline |
|
|
|
|
|
| PIPE-3297 |
|
|
|
|
|
| Piperidylthiambutene |
|
|
|
|
|
| Piperidylthiambutene hydrochloride |
|
|
|
|
|
| PL-017 |
|
|
|
|
|
| PL-017 TFA |
|
|
|
|
|
| PL265 |
|
|
|
|
|
| PL37 |
|
|
|
|
|
| Prodilidine hydrochloride |
|
|
|
|
|
| PZM21 |
|
|
|
|
99.87% |
| R-6890 |
|
|
|
|
99.59% |
| R-84760 |
|
|
|
|
|
| RB 101 |
|
|
|
|
|
| rel-SB-612111 hydrochloride |
|
|
|
|
|
| Riminkefon |
|
|
|
|
|
| RM1490 |
|
|
|
|
|
| Ro 64-6198 |
|
|
|
|
98.31% |
| Ro-48-6791 |
|
|
|
|
|
| RO-76 |
|
|
|
|
|
| RSD-921 |
|
|
|
|
|
| RU-24213 hydrochloride |
|
|
|
|
|
| RX809055AX |
|
|
|
|
|
| SalA-VS-07 |
|
|
|
|
|
| SalA-VS-08 |
|
|
|
|
|
| Salvinorin A |
|
|
|
|
98.99% |
| Salvinorin A carbamate |
|
|
|
|
|
| Salvinorin A propionate |
|
|
|
|
|
| Salvinorin B |
|
|
|
|
99.90% |
| Samidorphan |
|
|
|
|
99.04% |
| Samidorphan hydrochloride |
|
|
|
|
|
| Samidorphan isoquinoline dioxolane |
|
|
|
|
|
| Samidorphan-d5 |
|
|
|
|
|
| SB-612111 |
|
|
|
|
|
| SB-612111 hydrochloride |
|
|
|
|
99.64% |
| SC13 |
|
|
|
|
|
| SCH 221510 |
|
|
|
|
99.06% |
| SCH 221510 (Standard) |
|
|
|
|
|
| SCH 486757 |
|
|
|
|
|
| SDM25N hydrochloride |
|
|
|
|
|
| SHR0687 |
|
|
|
|
|
| Sialorphin |
|
|
|
|
|
| Sialorphin TFA |
|
|
|
|
|
| SNC162 |
|
|
|
|
99.72% |
| SNC80 |
|
|
|
|
99.82% |
| SNF 9007 |
|
|
|
|
|
| Spiradoline |
|
|
|
|
|
| Spiradoline mesylate |
|
|
|
|
99.81% |
| SR-14968 |
|
|
|
|
|
| SR-16434 |
|
|
|
|
|
| SR-8993 |
|
|
|
|
|
| SR14150 |
|
|
|
|
|
| SR16835 |
|
|
|
|
|
| SR17018 |
|
|
|
|
99.22% |
| SRI-22136 |
|
|
|
|
|
| SYK-1106 |
|
|
|
|
|
| SYK-1106 dihydrochloride |
|
|
|
|
|
| TAN-452 |
|
|
|
|
99.16% |
| TAN-67 |
|
|
|
|
|
| TAN-67 dihydrobromide |
|
|
|
|
99.2% |
| Tianeptine-d6 hydrochloride |
|
|
|
|
|
| TIPP |
|
|
|
|
|
| Tramadol N-oxide |
|
|
|
|
|
| Trap-101 hydrochloride |
|
|
|
|
|
| TRK-851 |
|
|
|
|
|
| TRPV1 antagonist 11 |
|
|
|
|
|
| TRV0109101 |
|
|
|
|
|
| Tyr-Ala-N-(1,3-dimethylbutyl)glycinamide |
|
|
|
|
|
| Tyr-W-MIF-1 |
|
|
|
|
|
| U-48520 |
|
|
|
|
|
| U-49900 |
|
|
|
|
|
| U-54494A |
|
|
|
|
|
| U-69593 |
|
|
|
|
99.73% |
| UFP-101 |
|
|
|
|
|
| UFP-101 TFA |
|
|
|
|
99.36% |
| UFP-512 |
|
|
|
|
|
| Urotensin-II receptor antagonist-1 |
|
|
|
|
|
| Valorphin |
|
|
|
|
|
| Viminol |
|
|
|
|
|
| Volazocine |
|
|
|
|
|
| ZP 120C |
|
|
|
|
|
| ZT 52656A hydrochloride |
|
|
|
|
99.98% |
| α-Casein (90-95) |
|
|
|
|
99.51% |
| α-Casein (90-95) TFA |
|
|
|
|
99.58% |
| α-Endorphin (human) |
|
|
|
|
|
| α-Neoendorphin (1-8) |
|
|
|
|
|
| β-Casomorphin (1-5), bovine |
|
|
|
|
99.62% |
| β-Casomorphin (1-5), bovine TFA |
|
|
|
|
|
| β-Casomorphin, bovine |
|
|
|
|
99.85% |
| β-Casomorphin, bovine TFA |
|
|
|
|
|
| β-Casomorphin, human |
|
|
|
|
|
| β-Casomorphin, human TFA |
|
|
|
|
99.35% |
| β-Chlornaltrexamine dihydrochloride |
|
|
|
|
|
| β-Endorphin (1-27) (human) |
|
|
|
|
|
| β-Endorphin (6-31), human |
|
|
|
|
|
| β-Endorphin (rat) |
|
|
|
|
|
| β-Endorphin, equine |
|
|
|
|
|
| β-Endorphin, equine TFA |
|
|
|
|
97.10% |
| β-Endorphin, rat |
|
|
|
|
|
| β-Funaltrexamine |
|
|
|
|
|
| β-Lipotropin (60-65) |
|
|
|
|
|
| β-Lipotropin (61-69) |
|
|
|
|
|
| β-Endorphin, human |
|
|
|
|
98.94% |
| β-Funaltrexamine hydrochloride |
|
|
|
|
99.07% |
| δ opioid receptor antagonist 1 |
|
|
|
|
|
| μ opioid receptor agonist 1 |
|
|
|
|
|
| μ opioid receptor agonist 2 |
|
|
|
|
|
| μ opioid receptor agonist 3 |
|
|
|
|
|
| μ Opioid receptor agonist 4 |
|
|
|
|
|
| μ/κ/δ opioid receptor agonist 1 |
|
|
|
|
|
| σ1 Receptor/μ Opioid receptor modulator 1 |
|
|
|
|
|
| σ1 Receptor/μ Opioid receptor modulator 2 |
|
|
|
|
|
| Sec-O-Glucosylhamaudol |
|
|
|
|
99.81% |
| Enadoline |
|
|
|
|
|
| Endomorphin 1 |
|
|
|
|
99.92% |
| Endomorphin 2 |
|
|
|
|
|
| Endomorphin 2 TFA |
|
|
|
|
99.04% |
| Harmane |
|
|
|
|
99.91% |
| Harman-13C2,15N |
|
|
|
|
|
| Harmane hydrochloride |
|
|
|
|
99.88% |
| Tianeptine-d12 |
|
|
|
|
|
| Tianeptine |
|
|
|
|
99.21% |
| Tianeptine sodium salt |
|
|
|
|
99.71% |
| Kukoamine A |
|
|
|
|
99.88% |
| Nociceptin |
|
|
|
|
98.09% |
| Dynorphin B (1-13) |
|
|
|
|
98.49% |
| Dynorphin B (1-13) TFA |
|
|
|
|
99.58% |
| Dynorphin A |
|
|
|
|
99.09% |
| Dynorphin A TFA |
|
|
|
|
|
| Porcine dynorphin A(1-13) |
|
|
|
|
99.86% |
| Trimebutine |
|
|
|
|
99.42% |
| Trimebutine (Standard) |
|
|
|
|
98% |
| Trimebutine-d5 fumarate |
|
|
|
|
|
| Trimebutine-d3 hydrochloride |
|
|
|
|
|
| Bisacodyl |
|
|
|
|
99.71% |
| (RS)-Salsolinol hydrobromide |
|
|
|
|
|
| Loperamide oxide |
|
|
|
|
|
| N-Desmethylclozapine |
|
|
|
|
99.10% |
| N-Desmethylclozapine-d8 hydrochloride |
|
|
|
|
99.74% |
| Sameridine |
|
|
|
|
|
| Sameridine hydrochloride |
|
|
|
|
|
| Loperamide phenyl |
|
|
|
|
99.9% |
| Alvimopan-d7 |
|
|
|
|
|
| Alvimopan |
|
|
|
|
98.42% |
| Alvimopan dihydrate |
|
|
|
|
98.66% |
| Alvimopan metabolite |
|
|
|
|
|
| Alvimopan monohydrate |
|
|
|
|
|
| Cyclazocine |
|
|
|
|
|
| Dermorphin |
|
|
|
|
99.36% |
| Dermorphin TFA |
|
|
|
|
|
| Loperamide-d6 hydrochloride |
|
|
|
|
99.07% |
| Loperamide hydrochloride |
|
|
|
|
99.84% |
| Mianserin hydrochloride |
|
|
|
|
99.95% |
| Mianserin-d3 (hydrochloride) |
|
|
|
|
97.51% |
| Naloxone hydrochloride |
|
|
|
|
99.96% |
| Nalmefene hydrochloride |
|
|
|
|
99.19% |
| Noscapine hydrochloride |
|
|
|
|
99.87% |
| Sinomenine hydrochloride |
|
|
|
|
99.89% |
| Mianserin |
|
|
|
|
99.42% |
| Corydine |
|
|
|
|
99.93% |
| Corydaline |
|
|
|
|
99.70% |
| Naltrexone |
|
|
|
|
99.82% |
| Naltrexone-d4 |
|
|
|
|
99.82% |
| Natrexone/BSA |
|
|
|
|
|
| Naloxegol |
|
|
|
|
|
| Naloxegol-13C,d2 |
|
|
|
|
|
| Naloxegol oxalate |
|
|
|
|
99.91% |
| Naloxone |
|
|
|
|
99.71% |
| Naloxone-d5 |
|
|
|
|
|
| Nalmefene-d4 |
|
|
|
|
|
| Matrine-d3 |
|
|
|
|
|
| Matrine |
|
|
|
|
98.0% |
| Moguisteine |
|
|
|
|
99.92% |
| Tyr-Gly-Gly-Phe-Met-OH |
|
|
|
|
99.48% |
| Tyr-{Gly-13C2,15N}-Gly-Phe-Met-OH TFA |
|
|
|
|
|
| Tyr-Gly-{Gly-13C2,15N}-Phe-Met-OH TFA |
|
|
|
|
|
| Tyr-Gly-Gly-{Phe-13C9,15N}-Met-OH TFA |
|
|
|
|
|
| Noscapine |
|
|
|
|
99.98% |
| Axomadol |
|
|
|
|
99.74% |
| Asimadoline |
|
|
|
|
|
| Asimadoline hydrochloride (Standard) |
|
|
|
|
|
| Asimadoline hydrochloride |
|
|
|
|
99.57% |
| Sinomenine |
|
|
|
|
99.96% |
| Trimebutine maleate |
|
|
|
|
99.66% |
| Trimebutine maleate (Standard) |
|
|
|
|
98% |